栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/07 | 2,499 | 2,504 | 2,449 | 2,461 | -60 | -2.4% | 112,600 |
2019/02/06 | 2,530 | 2,560 | 2,513 | 2,521 | -3 | -0.1% | 89,900 |
2019/02/05 | 2,540 | 2,566 | 2,516 | 2,524 | +2 | +0.1% | 126,600 |
2019/02/04 | 2,480 | 2,545 | 2,480 | 2,522 | +82 | +3.4% | 158,400 |
2019/02/01 | 2,436 | 2,493 | 2,434 | 2,440 | -21 | -0.9% | 93,200 |
2019/01/31 | 2,500 | 2,520 | 2,440 | 2,461 | -68 | -2.7% | 320,600 |
2019/01/30 | 2,401 | 2,623 | 2,380 | 2,529 | +228 | +9.9% | 587,100 |
2019/01/29 | 2,232 | 2,315 | 2,213 | 2,301 | +64 | +2.9% | 149,500 |
2019/01/28 | 2,280 | 2,280 | 2,227 | 2,237 | +7 | +0.3% | 144,300 |
2019/01/25 | 2,283 | 2,289 | 2,230 | 2,230 | -64 | -2.8% | 179,800 |
2019/01/24 | 2,300 | 2,300 | 2,261 | 2,294 | -9 | -0.4% | 151,000 |
2019/01/23 | 2,330 | 2,340 | 2,300 | 2,303 | -67 | -2.8% | 120,900 |
2019/01/22 | 2,466 | 2,466 | 2,356 | 2,370 | -63 | -2.6% | 87,200 |
2019/01/21 | 2,453 | 2,461 | 2,400 | 2,433 | +2 | +0.1% | 72,700 |
2019/01/18 | 2,372 | 2,441 | 2,360 | 2,431 | +62 | +2.6% | 53,900 |
2019/01/17 | 2,429 | 2,429 | 2,349 | 2,369 | -65 | -2.7% | 122,100 |
2019/01/16 | 2,422 | 2,469 | 2,422 | 2,434 | +20 | +0.8% | 49,300 |
2019/01/15 | 2,348 | 2,434 | 2,344 | 2,414 | +16 | +0.7% | 59,400 |
2019/01/11 | 2,402 | 2,423 | 2,375 | 2,398 | +7 | +0.3% | 53,400 |
2019/01/10 | 2,412 | 2,433 | 2,386 | 2,391 | -43 | -1.8% | 75,400 |
2019/01/09 | 2,398 | 2,450 | 2,378 | 2,434 | +67 | +2.8% | 67,900 |
2019/01/08 | 2,383 | 2,401 | 2,360 | 2,367 | -17 | -0.7% | 82,000 |
2019/01/07 | 2,380 | 2,429 | 2,355 | 2,384 | +54 | +2.3% | 120,300 |
2019/01/04 | 2,357 | 2,359 | 2,281 | 2,330 | -77 | -3.2% | 209,900 |
2018/12/28 | 2,395 | 2,441 | 2,359 | 2,407 | +7 | +0.3% | 107,100 |
2018/12/27 | 2,301 | 2,427 | 2,287 | 2,400 | +208 | +9.5% | 157,000 |
2018/12/26 | 2,154 | 2,233 | 2,136 | 2,192 | +39 | +1.8% | 102,500 |
2018/12/25 | 2,251 | 2,255 | 2,140 | 2,153 | -232 | -9.7% | 138,400 |
2018/12/21 | 2,446 | 2,451 | 2,333 | 2,385 | -53 | -2.2% | 149,900 |
2018/12/20 | 2,518 | 2,557 | 2,433 | 2,438 | -87 | -3.4% | 129,100 |
2018/12/19 | 2,529 | 2,597 | 2,427 | 2,525 | -25 | -1% | 120,700 |
2018/12/18 | 2,533 | 2,588 | 2,505 | 2,550 | -15 | -0.6% | 99,100 |
2018/12/17 | 2,505 | 2,575 | 2,484 | 2,565 | +68 | +2.7% | 118,500 |
2018/12/14 | 2,496 | 2,518 | 2,475 | 2,497 | -10 | -0.4% | 93,000 |
2018/12/13 | 2,510 | 2,511 | 2,467 | 2,507 | +18 | +0.7% | 63,300 |
2018/12/12 | 2,440 | 2,504 | 2,440 | 2,489 | +50 | +2.1% | 54,500 |
2018/12/11 | 2,476 | 2,486 | 2,435 | 2,439 | -36 | -1.5% | 42,200 |
2018/12/10 | 2,532 | 2,535 | 2,474 | 2,475 | -61 | -2.4% | 55,000 |
2018/12/07 | 2,503 | 2,547 | 2,490 | 2,536 | +24 | +1% | 66,600 |
2018/12/06 | 2,539 | 2,539 | 2,490 | 2,512 | -42 | -1.6% | 70,100 |
2018/12/05 | 2,502 | 2,571 | 2,502 | 2,554 | +2 | +0.1% | 60,400 |
2018/12/04 | 2,613 | 2,618 | 2,535 | 2,552 | -56 | -2.1% | 126,800 |
2018/12/03 | 2,636 | 2,636 | 2,571 | 2,608 | +3 | +0.1% | 105,300 |
2018/11/30 | 2,581 | 2,640 | 2,562 | 2,605 | +48 | +1.9% | 171,900 |
2018/11/29 | 2,475 | 2,577 | 2,475 | 2,557 | +93 | +3.8% | 148,300 |
2018/11/28 | 2,534 | 2,534 | 2,444 | 2,464 | -44 | -1.8% | 151,500 |
2018/11/27 | 2,517 | 2,534 | 2,482 | 2,508 | +26 | +1% | 75,400 |
2018/11/26 | 2,477 | 2,501 | 2,460 | 2,482 | +6 | +0.2% | 66,600 |
2018/11/22 | 2,420 | 2,477 | 2,390 | 2,476 | +54 | +2.2% | 103,700 |
2018/11/21 | 2,377 | 2,476 | 2,377 | 2,422 | -36 | -1.5% | 121,600 |
1401~
1450
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム